Please enable JavaScript to continue using this application.

Compare $ORKA vs $SRRK | Chartloom

Compare

$ORKA vs $SRRK

Oruka Therapeutics Inc · Scholar Rock Holding Corp

ORKA

Oruka Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Compare $ORKA vs $SRRK

Comparing Oruka Therapeutics Inc and Scholar Rock Holding Corp

ORKAOruka Therapeutics Inc

SRRKScholar Rock Holding Corp

ORKAOruka Therapeutics Inc

Market cap

$4.95B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

190.4%

52W performance

263.0%

FCF yield

-2.0%

SRRKScholar Rock Holding Corp

Market cap

$5.06B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

122.55x

Rev growth (TTM)

—

YTD performance

-1.4%

52W performance

9.0%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ORKA

SRRK

Detailed metrics comparison

ORKA

Oruka Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Market Cap

ORKA$4.95B

SRRK$5.06B

Enterprise Value

ORKA$4.68B

SRRK$4.81B

Price

ORKA$82.11

SRRK$42.19

P/E Ratio

ORKAN/A

SRRKN/A

P/S Ratio

ORKA119.42x

SRRK120.52x

EV/Sales

ORKA113.69x

SRRK115.43x

EV/EBITDA

ORKA0.00x

SRRK0.00x

P/B Ratio

ORKA5.02x

SRRK22.46x

P/FCF Ratio

ORKAN/A

SRRKN/A

EV/FCF

ORKA-46.30x

SRRK-16.21x

PEG Ratio

ORKAN/A

SRRKN/A

Forward P/E (NTM)

ORKAN/A

SRRKN/A

Forward P/S (NTM)

ORKAN/A

SRRK122.55x

Revenue (TTM)

ORKA$0

SRRK$0

Revenue Growth (YoY)

ORKAN/A

SRRKN/A

Forward Rev Growth

ORKA679.2%

SRRK2628.0%

Gross Margin (TTM)

ORKA0.0%

SRRK0.0%

Operating Margin (TTM)

ORKA0.0%

SRRK0.0%

EBITDA Margin (TTM)

ORKA0.0%

SRRK0.0%

Net Margin (TTM)

ORKA0.0%

SRRK0.0%

FCF Margin (TTM)

ORKAN/A

SRRKN/A

Net Income (TTM)

ORKA$-133M

SRRK$-406M

FCF (TTM)

ORKA$-101M

SRRK$-297M

EPS (TTM)

ORKA-$2.11

SRRK-$3.11

ROE (TTM)

ORKA-2076.0%

SRRK-15912.0%

ROA (TTM)

ORKA-2012.0%

SRRK-8660.0%

ROIC (TTM)

ORKA-2076.0%

SRRK-10069.0%

Cash

ORKA$268M

SRRK$437M

Debt

ORKA$0

SRRK$196M

Net Cash/Debt

ORKA$268M

SRRK$241M

Current Ratio (TTM)

ORKA38.51x

SRRK7.02x

Quick Ratio (TTM)

ORKA38.03x

SRRK6.84x

Debt/Equity (TTM)

ORKA0.00x

SRRK0.77x

Debt/Assets (TTM)

ORKA0.0%

SRRK0.0%

Interest Coverage (TTM)

ORKAN/A

SRRKN/A

Net Debt/EBITDA (TTM)

ORKA0.00x

SRRK0.00x

Beta

ORKA-0.40

SRRK0.76

52W Performance

ORKA263.0%

SRRK9.0%

YTD Performance

ORKA190.4%

SRRK-1.4%

% from 52W High

ORKA-28.9%

SRRK-31.7%

% from 52W Low

ORKA279.1%

SRRK55.9%

Asset Turnover (TTM)

ORKA0.33x

SRRK0.16x

FCF Yield (TTM)

ORKA-2.0%

SRRK-5.9%

Earnings Yield (TTM)

ORKA-2.7%

SRRK-8.0%

Dividend Yield (TTM)

ORKAN/A

SRRKN/A

Rule of 40

ORKA0.0

SRRK0.0

EV/GP/RG

ORKAN/A

SRRKN/A

Ticker research

View ORKA research View SRRK research

Metric	ORKA Oruka Therapeutics Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$4.95B	$5.06B
Enterprise Value	$4.68B	$4.81B
Price	$82.11	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	119.42x	120.52x
EV/Sales	113.69x	115.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.02x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-46.30x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	122.55x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	679.2%	2628.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-133M	$-406M
FCF (TTM)	$-101M	$-297M
EPS (TTM)	-$2.11	-$3.11
ROE (TTM)	-2076.0%	-15912.0%
ROA (TTM)	-2012.0%	-8660.0%
ROIC (TTM)	-2076.0%	-10069.0%
Financial Health
Cash	$268M	$437M
Debt	$0	$196M
Net Cash/Debt	$268M	$241M
Current Ratio (TTM)	38.51x	7.02x
Quick Ratio (TTM)	38.03x	6.84x
Debt/Equity (TTM)	0.00x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.40	0.76
52W Performance	263.0%	9.0%
YTD Performance	190.4%	-1.4%
% from 52W High	-28.9%	-31.7%
% from 52W Low	279.1%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.16x
FCF Yield (TTM)	-2.0%	-5.9%
Earnings Yield (TTM)	-2.7%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ORKA research	View SRRK research

Valuation

P/S Ratio

ORKA

119.42x

SRRK

120.52x

EV/FCF

ORKA

-46.30x

SRRK

-16.21x

Growth & revenue

Forward Revenue Growth

SRRK

2628.0%

ORKA

679.2%

Profitability & performance

Gross Margin

ORKA

0.0%

SRRK

0.0%

ROE

ORKA

-2076.0%

SRRK

-15912.0%

FCF Yield %

ORKA

-2.0%

SRRK

-5.9%

52-Week Performance

ORKA

263.0%

SRRK

9.0%

Detailed metrics comparison

ORKA

Oruka Therapeutics Inc

SRRK

Scholar Rock Holding Corp

Market Cap

ORKA$4.95B

SRRK$5.06B

Enterprise Value

ORKA$4.68B

SRRK$4.81B

Price

ORKA$82.11

SRRK$42.19

P/E Ratio

ORKAN/A

SRRKN/A

P/S Ratio

ORKA119.42x

SRRK120.52x

EV/Sales

ORKA113.69x

SRRK115.43x

EV/EBITDA

ORKA0.00x

SRRK0.00x

P/B Ratio

ORKA5.02x

SRRK22.46x

P/FCF Ratio

ORKAN/A

SRRKN/A

EV/FCF

ORKA-46.30x

SRRK-16.21x

PEG Ratio

ORKAN/A

SRRKN/A

Forward P/E (NTM)

ORKAN/A

SRRKN/A

Forward P/S (NTM)

ORKAN/A

SRRK122.55x

Revenue (TTM)

ORKA$0

SRRK$0

Revenue Growth (YoY)

ORKAN/A

SRRKN/A

Forward Rev Growth

ORKA679.2%

SRRK2628.0%

Gross Margin (TTM)

ORKA0.0%

SRRK0.0%

Operating Margin (TTM)

ORKA0.0%

SRRK0.0%

EBITDA Margin (TTM)

ORKA0.0%

SRRK0.0%

Net Margin (TTM)

ORKA0.0%

SRRK0.0%

FCF Margin (TTM)

ORKAN/A

SRRKN/A

Net Income (TTM)

ORKA$-133M

SRRK$-406M

FCF (TTM)

ORKA$-101M

SRRK$-297M

EPS (TTM)

ORKA-$2.11

SRRK-$3.11

ROE (TTM)

ORKA-2076.0%

SRRK-15912.0%

ROA (TTM)

ORKA-2012.0%

SRRK-8660.0%

ROIC (TTM)

ORKA-2076.0%

SRRK-10069.0%

Cash

ORKA$268M

SRRK$437M

Debt

ORKA$0

SRRK$196M

Net Cash/Debt

ORKA$268M

SRRK$241M

Current Ratio (TTM)

ORKA38.51x

SRRK7.02x

Quick Ratio (TTM)

ORKA38.03x

SRRK6.84x

Debt/Equity (TTM)

ORKA0.00x

SRRK0.77x

Debt/Assets (TTM)

ORKA0.0%

SRRK0.0%

Interest Coverage (TTM)

ORKAN/A

SRRKN/A

Net Debt/EBITDA (TTM)

ORKA0.00x

SRRK0.00x

Beta

ORKA-0.40

SRRK0.76

52W Performance

ORKA263.0%

SRRK9.0%

YTD Performance

ORKA190.4%

SRRK-1.4%

% from 52W High

ORKA-28.9%

SRRK-31.7%

% from 52W Low

ORKA279.1%

SRRK55.9%

Asset Turnover (TTM)

ORKA0.33x

SRRK0.16x

FCF Yield (TTM)

ORKA-2.0%

SRRK-5.9%

Earnings Yield (TTM)

ORKA-2.7%

SRRK-8.0%

Dividend Yield (TTM)

ORKAN/A

SRRKN/A

Rule of 40

ORKA0.0

SRRK0.0

EV/GP/RG

ORKAN/A

SRRKN/A

Ticker research

View ORKA research View SRRK research

Metric	ORKA Oruka Therapeutics Inc	SRRK Scholar Rock Holding Corp
Market & Valuation
Market Cap	$4.95B	$5.06B
Enterprise Value	$4.68B	$4.81B
Price	$82.11	$42.19
P/E Ratio	N/A	N/A
P/S Ratio	119.42x	120.52x
EV/Sales	113.69x	115.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	5.02x	22.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-46.30x	-16.21x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	122.55x
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	679.2%	2628.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-133M	$-406M
FCF (TTM)	$-101M	$-297M
EPS (TTM)	-$2.11	-$3.11
ROE (TTM)	-2076.0%	-15912.0%
ROA (TTM)	-2012.0%	-8660.0%
ROIC (TTM)	-2076.0%	-10069.0%
Financial Health
Cash	$268M	$437M
Debt	$0	$196M
Net Cash/Debt	$268M	$241M
Current Ratio (TTM)	38.51x	7.02x
Quick Ratio (TTM)	38.03x	6.84x
Debt/Equity (TTM)	0.00x	0.77x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.40	0.76
52W Performance	263.0%	9.0%
YTD Performance	190.4%	-1.4%
% from 52W High	-28.9%	-31.7%
% from 52W Low	279.1%	55.9%
Efficiency & Yields
Asset Turnover (TTM)	0.33x	0.16x
FCF Yield (TTM)	-2.0%	-5.9%
Earnings Yield (TTM)	-2.7%	-8.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View ORKA research	View SRRK research